Catalyst Wire Dossier Catalyst Wire Dossier

RIVFLOZA

NEDOSIRAN · Novo Nordisk
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RIVFLOZA, covering 2023-09-29 to 2025-03-27. Get the full timeline:

Most recent: FDA Approved: RIVFLOZA — Supplemental Application (Novo Nordisk)

See pricing